Nascent Biotech (NBIO) Financial Statements
Nascent Biotech Financial Overview
Nascent Biotech's market cap is currently $34.57K. The company's EPS TTM is $-0.01; its P/E ratio is -0.01; Nascent Biotech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 1.00M | $ 750.00K | $ 0.00 |
| Gross Profit | $ -320.00K | $ 0.00 | $ 1.00M | $ 750.00K | $ 0.00 |
| Operating Income | $ -2.23M | $ -2.16M | $ -457.00K | $ -1.40M | $ -3.45M |
| EBITDA | $ 527.88K | $ -812.72K | $ 52.00 | $ 797.65K | $ -470.69K |
| Net Income | $ -2.09M | $ -2.80M | $ -470.00K | $ -959.00K | $ -4.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 372.12K | $ 172.19K | $ 94.41K | $ 1.44K | $ 3.22K |
| Total Assets | $ 552.12K | $ 255.00K | $ 105.41K | $ 751.43K | $ 3.22K |
| Total Debt | $ 122.50K | $ 389.59K | $ 0.00 | $ 161.74K | $ 138.81K |
| Net Debt | $ -249.62K | $ 217.41K | $ -94.41K | $ 160.30K | $ 135.60K |
| Total Liabilities | $ 808.79K | $ 1.55M | $ 776.89K | $ 1.22M | $ 2.88M |
| Stockholders' Equity | $ -256.67K | $ -1.30M | $ -671.48K | $ -472.50K | $ -2.88M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.19M | $ -1.79M | $ 413.48K | $ -986.78K | $ -554.33K |
| Operating Cash Flow | $ -1.19M | $ -1.79M | $ 413.48K | $ -986.78K | $ -554.33K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 1.39M | $ 1.86M | $ -320.50K | $ 985.00K | $ 426.07K |
Currency in USD
